Brightgene Bio-Medical Technology Co., Ltd.

The Bright-Gene is a fast-growing biopharmaceutical company that engages in the research, development and manufacturing of Active Pharmaceutical Ingredients and Intermediates with primary focus on the high-end API market and late-stage drug candidates. We established in 2001, In 2008, its turnover reached $5, 000, 000, and 90% of the products were exported to overseas. The Bright-gene always cares about quality management system. The eight drugs of our company have had the GMP certificates of SFDA, and the product quality meet the standards of the national pharmacopoeia in China, America, England and Japan. We have perfect quality system on product progress, now we have one R&D centre and three workshop which produce the entecavir, Dasatinib and Posaconazole separately.